Flow cytometry has transformed researchers’ ability to profile cells, but the technology’s low throughput initially restricted its use in the pharmaceutical sector. However, advances in terms of reagents, antibodies, and flow cytometer technology permit scientists to characterize more cellular features per experiment and automate the entire workflow. These changes have led scientists to adopt flow cytometry throughout their drug discovery workflows, including target identification, lead selection, and safety studies.
Download this ebook from Bio-Rad to learn how
- Researchers identify and deeply phenotype cells with flow cytometry
- Novel reagents and technologies facilitate and expand multicolor panel design
- Automated flow cytometry accelerates high-throughput screens
